๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial

โœ Scribed by Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wanling Xie; Fiona M. Fennessy; Rupal S. Bhatt; Julia Hayes; Toni K. Choueiri; Clare M. Tempany; Philip W. Kantoff; Mary E. Taplin; William K. Oh

Book ID
112067081
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
253 KB
Volume
118
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of neoadjuvant docetaxel
Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer
โœ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib